Early detection of CTEPH after pulmonary embolism
Part of Lungs & breathing clinical trials.
This trial is for people who had a pulmonary embolism (a blood clot in the lungs) in the last 3 to 12 months and are still on blood thinners. It aims to find early signs of a serious condition called CTEPH (chronic blood clots in the lungs) so treatment can start sooner.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older.
- You had a pulmonary embolism (blood clot in the lungs) between 3 and 12 months ago.
- You are currently taking blood thinners (anticoagulation therapy).
- You either have new or worsening shortness of breath (at least NYHA class II), OR you have no symptoms but have at least one specific risk factor (like certain blood disorders, an infected device in your body, or a history of certain surgeries or diseases).
- You are willing to sign a consent form to participate in the study and allow use of your data.
- You do not have any medical reason that would prevent you from receiving treatment for this condition.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial studies a structured pulmonary (lung) rehabilitation program for people who still have breathing and activity problems after a pulmonary embolism (PE). It may help improve physical ability and function during recovery.
This study builds a registry to learn about people with chronic blood-clot lung disease (CTEPD/CTEPH) and what symptoms and test results look like over time. It may help clinicians better understand the condition and improve future care, since your participation supports data collection rather than a new drug.
This trial tests whether a procedure called balloon pulmonary angioplasty is safe and effective for people with chronic thromboembolic disease in the lungs, especially when surgery isn’t an option. If you have CTEPH, it may help improve lung blood flow and symptoms.
This trial is for people with a type of long-term blood clot in the lungs (CTEPH) who have been taking riociguat for at least 12 weeks. It will see what happens when the medication is stopped, focusing on how the right side of the heart is doing.
This trial tests a new treatment for people with a severe, high-risk pulmonary embolism (blood clot in the lung). It uses a catheter device to remove the clot and help the heart work better.
This study tests whether a small implanted sensor (CardioMEMS) that monitors pressure in the lung artery can help doctors detect and manage complications after surgery for chronic blood clots in the lungs. It aims to improve recovery and long-term outcomes.
Hear when a new Chronic Pulmonary Thromboembolism trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.